
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Histone cluster 1 H1E CRISPR/Cas9 KO Plasmid (h) | sc-402775 | 20 µg | $397.00 |
HIST1H1E encodes histone cluster 1 H1E, a replication-dependent linker histone H1 variant that binds nucleosomal DNA to stabilize higher-order chromatin structure and influence genome compaction. By modulating chromatin accessibility, H1E helps regulate transcriptional programs, DNA replication timing, and DNA damage responses through effects on chromatin remodeling and repair factor recruitment. Altered H1 family stoichiometry and linker-histone dynamics have been associated with epigenetic dysregulation observed in cancer and neurodevelopmental disorders, and HIST1H1E-related perturbations can impact cell fate decisions and genomic stability. As part of the Histone cluster 1 locus, HIST1H1E is also relevant for studies of S-phase–coupled histone expression and chromatin assembly.
Histone cluster 1 H1E CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the HIST1H1E gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the HIST1H1E together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the HIST1H1E open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Histone cluster 1 H1E protein expression.
This CRISPR knockout system enables efficient generation of HIST1H1E-deficient cell models for investigation of Histone cluster 1 H1E signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.